A trial looking at different combinations of treatment for newly diagnosed myeloma (RADAR, Myeloma XV)

This trial is looking at bone marrow samples to help work out the best treatment for myeloma. It is also looking at measuring small amounts of myeloma cells that may be present after initial treatment. This is called minimal residual disease or MRD.

It is for people who:

• are suitable to have a stem cell transplant and

• haven’t had treatment for myeloma

Cancer Research UK supports this trial.